CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $106,000 | -53.3% | 15,062 | -68.2% | 0.00% | – |
Q4 2020 | $227,000 | -16.8% | 47,299 | +0.9% | 0.00% | – |
Q3 2020 | $273,000 | -13.6% | 46,889 | +0.0% | 0.00% | – |
Q2 2020 | $316,000 | +6.0% | 46,878 | +0.1% | 0.00% | – |
Q1 2020 | $298,000 | -64.7% | 46,811 | -42.3% | 0.00% | -100.0% |
Q4 2019 | $845,000 | +78.6% | 81,089 | -32.6% | 0.00% | 0.0% |
Q3 2019 | $473,000 | -73.6% | 120,276 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $1,789,000 | -29.7% | 120,276 | +1.1% | 0.00% | 0.0% |
Q1 2019 | $2,545,000 | +138.5% | 118,982 | +100.2% | 0.00% | +100.0% |
Q4 2018 | $1,067,000 | -38.9% | 59,431 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $1,745,000 | -34.2% | 59,431 | +1.9% | 0.00% | -33.3% |
Q2 2018 | $2,651,000 | +4.7% | 58,306 | +21.6% | 0.00% | 0.0% |
Q1 2018 | $2,532,000 | -22.4% | 47,961 | 0.0% | 0.00% | -25.0% |
Q4 2017 | $3,261,000 | +48.6% | 47,961 | +80.1% | 0.00% | +33.3% |
Q3 2017 | $2,195,000 | – | 26,633 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |